| Product Code: ETC6739157 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Cell And Gene Therapy Clinical Trial Services Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, 2021 & 2031F |
3.3 China Cell And Gene Therapy Clinical Trial Services Market - Industry Life Cycle |
3.4 China Cell And Gene Therapy Clinical Trial Services Market - Porter's Five Forces |
3.5 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Phase, 2021 & 2031F |
3.7 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Therapeutic Areas, 2021 & 2031F |
3.8 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
4 China Cell And Gene Therapy Clinical Trial Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in cell and gene therapy research and development in China |
4.2.2 Growing prevalence of genetic disorders and chronic diseases |
4.2.3 Favorable regulatory environment supporting cell and gene therapy clinical trials in China |
4.3 Market Restraints |
4.3.1 High cost associated with cell and gene therapy clinical trials |
4.3.2 Limited expertise and infrastructure for conducting complex clinical trials |
4.3.3 Stringent regulatory requirements for cell and gene therapy trials in China |
5 China Cell And Gene Therapy Clinical Trial Services Market Trends |
6 China Cell And Gene Therapy Clinical Trial Services Market, By Types |
6.1 China Cell And Gene Therapy Clinical Trial Services Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Site Identification, 2021- 2031F |
6.1.4 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Patient Recruitment, 2021- 2031F |
6.1.5 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Laboratory Services, 2021- 2031F |
6.1.6 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Regulatory Services, 2021- 2031F |
6.1.7 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Supply and Logistic Services, 2021- 2031F |
6.1.8 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Cell And Gene Therapy Clinical Trial Services Market, By Phase |
6.2.1 Overview and Analysis |
6.2.2 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase I, 2021- 2031F |
6.2.3 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase II, 2021- 2031F |
6.2.4 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase III, 2021- 2031F |
6.2.5 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase IV, 2021- 2031F |
6.3 China Cell And Gene Therapy Clinical Trial Services Market, By Therapeutic Areas |
6.3.1 Overview and Analysis |
6.3.2 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Oncology, 2021- 2031F |
6.3.3 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Central Nervous System (CNS) Disorders, 2021- 2031F |
6.3.4 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.3.5 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.3.6 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Musculoskeletal, 2021- 2031F |
6.3.7 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Cell And Gene Therapy Clinical Trial Services Market, By Therapy Type |
6.4.1 Overview and Analysis |
6.4.2 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.4.3 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Gene-modified Cell Therapy, 2021- 2031F |
6.4.4 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.4.5 China Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F |
7 China Cell And Gene Therapy Clinical Trial Services Market Import-Export Trade Statistics |
7.1 China Cell And Gene Therapy Clinical Trial Services Market Export to Major Countries |
7.2 China Cell And Gene Therapy Clinical Trial Services Market Imports from Major Countries |
8 China Cell And Gene Therapy Clinical Trial Services Market Key Performance Indicators |
8.1 Number of new cell and gene therapy clinical trials initiated in China |
8.2 Percentage increase in funding allocated to cell and gene therapy research in China |
8.3 Average time taken for regulatory approval of cell and gene therapy trials in China |
9 China Cell And Gene Therapy Clinical Trial Services Market - Opportunity Assessment |
9.1 China Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 China Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Phase, 2021 & 2031F |
9.3 China Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Therapeutic Areas, 2021 & 2031F |
9.4 China Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
10 China Cell And Gene Therapy Clinical Trial Services Market - Competitive Landscape |
10.1 China Cell And Gene Therapy Clinical Trial Services Market Revenue Share, By Companies, 2024 |
10.2 China Cell And Gene Therapy Clinical Trial Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here